• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

paul.beavis@unimelb.edu.au

Credentials


Position
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-2116-013X

A/Prof Paul Beavis

Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology

62 Scholarly works
21 Projects

HIGHLIGHTS

  • 2026

    Journal article

    High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustion
    DOI: 10.1038/s41467-026-69671-y
  • 2026

    Journal article

    Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8 T cells in lymph nodes
    DOI: 10.1038/s41590-026-02419-4
  • 2026

    Journal article

    Implantable drug delivery system improves tolerability of anti-CD40/anti-PD1 and chemotherapy in a murine model of breast cancer
    DOI: 10.1016/j.ejps.2025.107359
  • 2026

    Journal article

    CDK4/6 inhibition enhances CAR-T cell therapy in solid tumors
    DOI: 10.1016/j.ymthe.2026.03.024
  • 2026

    Research grants (ARC, NHMRC, MRFF)

    Gene Engineering Approaches to Enhance the Efficacy of Adoptive Cellular Therapy of Cancer
  • 2024

    Research grants (international)

    Enhancing the Efficacy of Adoptive Cellular Therapy Through Advanced Genome Engineering
  • 2022

    Research grants (ARC, NHMRC, MRFF)

    Engineering Chimeric Antigen Receptor (CAR) T Cells That Induce Host Antitumour Immunity
Paul Beavis

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors
    DOI: 10.1038/s41467-025-59021-9
  • 2025

    Journal article

    Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8 T cell immunity against melanoma
    DOI: 10.1016/j.immuni.2025.10.004
  • 2025

    Journal article

    Development of a novel CAR-T cell therapy using a multimodal approach to target T cell lymphoma
    DOI: 10.1182/blood-2025-4112
  • 2025

    Journal article

    Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery
    DOI: 10.1038/s41586-025-09212-7
  • 2025

    Journal article

    27P CAR-T cells secreting tumour-specific bispecific engagers for solid tumour treatment
    DOI: 10.1016/j.esmoop.2025.105374
  • 2025

    Journal article

    Interleukin-4 modulates type I interferon to augment antitumor immunity
    DOI: 10.1126/sciadv.adt3618

RECENT PROJECTS

  • 2026

    Research grants (ARC, NHMRC, MRFF)

    Unraveling Metastasis-Specific Immune Niches to Transform Cancer Treatment
  • 2024

    Research grants (other domestic)

    New Frontiers for CAR T Cell Therapy in Breast Cancer

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224